TIDMIGP
RNS Number : 7212D
Intercede Group PLC
08 December 2009
?
8 DECEMBER 2009
INTERCEDE GROUP plc
('Intercede', 'the Company' or 'the Group')
Interim Results for the 6 Months Ended 30 September 2009
Intercede (AIM: IGP.L) is a leading producer of Identity and Credential
Management software, called MyID, which manages the secure registration,
issuance and life cycle of digital identities for a wide range of uses.
SUMMARY
- 42% increase in sales to GBP2,811,000 (2008: GBP1,981,000).
- Operating profit before exceptional items of GBP674,000 (2008:
GBP268,000).
- Profit before tax of GBP85,000 (2008: GBP222,000).
- Cash inflow of GBP202,000 (2008: GBP686,000).
- Cash balances of GBP3,913,000 at 30 September 2009 (30 September 2008:
GBP1,839,000).
- All external borrowings eliminated following the decision of the
convertible loan note holders to
convert their loan notes into
ordinary shares.
- Release of MyID 8 SR1, a major upgrade to the MyID platform.
- Successful deployment of MyID into two National ID schemes that have
entered 'live' production.
- Continued expansion of Intercede's customer base in the US in partnership
with VeriSign.
- Winning new contracts to supply MyID to government ministries, banks and
business
corporations around the world.
- Intercede overtakes competitors to be No1 in class as measured by the
number of contract
wins announced during the period.
Richard Parris, Chairman & Chief Executive of Intercede, said today:
"Our performance continues to grow in line with our expectations. Intercede has
now delivered three consecutive half year periods of profitability as a result
of substantial revenue growth. This growth is driven by a combination of
recurring sales to existing installations, demand from new customers and an
expansion of both our product scope and geographical reach. We remain very
excited about the size and scope of contracts we are working on and the
potential of our strongest ever sales pipeline."
ENQUIRIES
+-----------------------------------------+-------------------------------------+
| Intercede Group plc | Tel.+44 (0)1455 558111 |
+-----------------------------------------+-------------------------------------+
| Richard Parris, Chairman & Chief | |
| Executive | |
+-----------------------------------------+-------------------------------------+
| Andrew Walker, Finance Director | |
+-----------------------------------------+-------------------------------------+
| | |
+-----------------------------------------+-------------------------------------+
| FinnCap | |
+-----------------------------------------+-------------------------------------+
| Charles Cunningham | Tel. +44 (0)20 7600 1658 |
+-----------------------------------------+-------------------------------------+
| | |
+-----------------------------------------+-------------------------------------+
| Pelham Public Relations | |
+-----------------------------------------+-------------------------------------+
| Archie Berens | Tel.+44 (0)20 7337 1509 |
+-----------------------------------------+-------------------------------------+
| Francesca Tuckett | Tel.+44 (0)20 7337 1537 |
+-----------------------------------------+-------------------------------------+
About Intercede
Intercede is the producer of the MyID Identity and Credential Management System
(IDCMS). Intercede's MyID is the only IDCMS software product that enables
organizations to easily and securely manage the identities of people and their
associated identity credentials within a single, integrated, workflow driven
platform. This includes enabling and managing: secure registration, biometric
capture, application vetting and approval through to smart card personalization,
issuance and management.
Intercede's MyID is being used around the world by large corporations,
governments and banks to manage millions of identities for employees, citizens
and customers. Notable deployments in the US include 10 Federal Agencies, a
programme with Lockheed Martin and two major US financial institutions. In
Europe and the Middle East, Intercede's MyID is being deployed in support of
government identity, health and corporate employee ID security projects.
Intercede and MyID are registered trademarks or trademarks in the UK, US and/or
other countries.
For more information visit http://www.intercede.com.
INTERCEDE GROUP plc
Interim Results for the Six Months Ended 30 September 2009
Chairman's Statement
Introduction
I am pleased to be able to report that excellent commercial and technical
progress has been made during the first half of the year. Revenues have
increased by 42% to GBP2,811,000 (2008: GBP1,981,000), resulting in an operating
profit before exceptional items of GBP674,000 compared to GBP268,000 in the same
period last year.
As a result of this improved performance and careful cash management, cash
balances at 30 September 2009 totaled GBP3,913,000, which compares to
GBP3,711,000 at 31 March 2009 and GBP1,839,000 at 30 September 2008. All
external borrowings have also been eliminated during the period following the
decision of the convertible loan note holders to convert their loan notes into
ordinary shares.
This represents a turning point in the evolution of Intercede's business and is
indicative of the strong commercial progress we continue to make.
Commercial Progress
Significant advances during the year to date include:
* Successful commissioning of two National ID schemes powered by MyID; one in
Kuwait and the other for an undisclosed government customer.
* Winning new US Federal and State government customers in partnership with
VeriSign.
* Securing MyID sales with a Middle Eastern oil company, manufacturing companies
in Austria and Switzerland, government ministries in Romania and Slovakia, and
banks in Australia, the Czech Republic, Scandinavia and the Ukraine.
* Winning a contract with a major security printing and smart card manufacturer
for issuing identity cards to their employees at facilities around the world.
* Selling an additional 100,000 MyID licenses to BT for the NHS Data Spine project
which takes the total sold to date up to 700,000.
* Securing additional orders totaling in excess of $1.0m for MyID software
licenses and professional services in support of the internal identity badge of
the world's largest defence contractor, Lockheed Martin.
* Supporting Lockheed Martin on the US Transportation Worker Identity Credential
(TWIC) program which has to date resulted in the issuance of 1.3 million cards
to US dock workers using MyID.
* Worked with a US partner to win a multi-year contract to supply MyID to a large
US based, global management consultancy group for internal security and
regulatory compliance.
* The addition of the US Social Security Administration (SSA) to Intercede's
HSPD-12 customer list.
* The deployment of MyID 8 SR1 to two existing US Air Force base customers.
Following the successful launch of MyID 8 in June 2008, which repositioned MyID
from being a smart card management system to a fully featured Identity and
Credential Management System, MyID 8 SR1 was released on 26 October 2009. This
updated version includes support for a wide range of third party systems and
devices and enables partners and systems integrators to add value faster using
Intercede's revolutionary Project Designer suite of Application Programming
Interfaces (APIs) and customisation tools.
Financial Results
The financial results reflect the continued momentum from the Group's
involvement in an increasing number of projects around the world.
Sales increased by 42% to GBP2,811,000 (2008: GBP1,981,000) which resulted in a
substantial increase in operating profit before exceptional items from
GBP268,000 to GBP674,000. Exceptional costs incurred during the period as a
result of the ActivIdentity patent infringement lawsuit outlined below totaled
GBP579,000 (2008: GBPnil).
Staff costs continue to represent the main area of expense representing
approximately 80% of the total operating costs excluding exceptional items. The
average number of employees increased from 44 to 54 year on year.
A profit for the period of GBP85,000 (2008: GBP283,000) resulted in a basic
earnings per share of 0.2p (2008: 0.8p) and a fully diluted earnings per share
of 0.2p (2008: 0.6p). Adjusting for the exceptional costs results in a fully
diluted pre exceptional earnings per share of 1.4p (2008: 0.6p).
Cash balances at 30 September 2009 totaled GBP3,913,000 (2008: GBP1,839,000) and
were therefore more than double that of a year ago, notwithstanding the
exceptional legal costs incurred to date as a result of the ActivIdentity patent
infringement lawsuit. During the period, the Group's financial position has also
been substantially strengthened following the decision of all of the convertible
loan note holders to convert their loan notes into ordinary shares.
Intellectual Property
The reported period includes exceptional costs for defending a previously
reported patent infringement case which was filed in the US by ActivIdentity
Corporation on 1 October 2008. Intercede's answer and counterclaims deny that
its products infringe ActivIdentity's patent and allege further that this patent
is invalid and unenforceable. In addition, Intercede has filed counterclaims
against ActivIdentity alleging violations of US antitrust law. Intercede intends
to pursue its defence and its counterclaims vigorously.
Outlook
The first half of the year has been profitable and cash generative. As in
previous years, the full year outcome will be dependent upon the timing of
receipt of orders and our subsequent ability to deliver and recognise revenues
in accordance with the Group's accounting policy. Nevertheless, the level and
pace of customer and partner activity is greater than in previous periods and
the sales pipeline is stronger than ever. I therefore remain confident that our
operating performance will continue to meet expectations.
Richard Parris
Chairman & Chief Executive
8 December 2009
Intercede Group plc
Consolidated Statement of Comprehensive Income
+-----------------------------+------------------+-----------------+--------------+
| | 6 months ended | 6 months ended | Year ended |
+-----------------------------+------------------+-----------------+--------------+
| | 30 September | 30 September | 31 March |
+-----------------------------+------------------+-----------------+--------------+
| | 2009 | 2008 | 2009 |
+-----------------------------+------------------+-----------------+--------------+
| | GBP'000 | GBP'000 | GBP'000 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Continuing operations | | | |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Revenue | 2,811 | 1,981 | 5,701 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Cost of sales | (73) | (25) | (41) |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Gross profit | 2,738 | 1,956 | 5,660 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Administrative expenses | (2,643) | (1,688) | (4,173) |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Operating profit | 95 | 268 | 1,487 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Operating profit before | 674 | 268 | 1,858 |
| exceptional item | | | |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Exceptional item | (579) | - | (371) |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Operating profit | 95 | 268 | 1,487 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Finance income | 16 | 28 | 68 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Finance costs | (26) | (74) | (147) |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Profit before tax | 85 | 222 | 1,408 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Tax | - | 61 | 341 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Profit for the period | 85 | 283 | 1,749 |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Total comprehensive income | 85 | 283 | 1,749 |
| attributable to owners of | | | |
| the company | | | |
+-----------------------------+------------------+-----------------+--------------+
| | | | |
+-----------------------------+------------------+-----------------+--------------+
| Earnings per share (pence) | | | |
+-----------------------------+------------------+-----------------+--------------+
| - basic | 0.2p | 0.8p | 4.7p |
+-----------------------------+------------------+-----------------+--------------+
| - diluted | 0.2p | 0.6p | 3.6p |
+-----------------------------+------------------+-----------------+--------------+
Intercede Group plc
Consolidated Balance Sheet
+-----------------------------+---------------+---------------+---------------+
| | As at | As at | As at |
+-----------------------------+---------------+---------------+---------------+
| | 30 September | 30 September | 31 March |
+-----------------------------+---------------+---------------+---------------+
| | 2009 | 2008 | 2009 |
+-----------------------------+---------------+---------------+---------------+
| | GBP'000 | GBP'000 | GBP'000 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Non-current assets | | | |
+-----------------------------+---------------+---------------+---------------+
| Property, plant and | 70 | 57 | 67 |
| equipment | | | |
+-----------------------------+---------------+---------------+---------------+
| Deferred tax | 280 | - | 280 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| | 350 | 57 | 347 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Current assets | | | |
+-----------------------------+---------------+---------------+---------------+
| Trade and other receivables | 687 | 866 | 902 |
+-----------------------------+---------------+---------------+---------------+
| Cash and cash equivalents | 3,913 | 1,839 | 3,711 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| | 4,600 | 2,705 | 4,613 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Total assets | 4,950 | 2,762 | 4,960 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Equity | | | |
+-----------------------------+---------------+---------------+---------------+
| Called up share capital | 4,413 | 4,302 | 4,305 |
+-----------------------------+---------------+---------------+---------------+
| Share premium account | 4,718 | 2,834 | 2,875 |
+-----------------------------+---------------+---------------+---------------+
| Other reserves | 1,508 | 1,508 | 1,508 |
+-----------------------------+---------------+---------------+---------------+
| Equity reserve | - | 109 | 109 |
+-----------------------------+---------------+---------------+---------------+
| Retained earnings | (7,908) | (9,568) | (8,102) |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Total equity | 2,731 | (815) | 695 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Current liabilities | | | |
+-----------------------------+---------------+---------------+---------------+
| Trade and other payables | 1,025 | 493 | 1,156 |
+-----------------------------+---------------+---------------+---------------+
| Deferred revenue | 1,194 | 1,177 | 1,173 |
+-----------------------------+---------------+---------------+---------------+
| Convertible loan notes | - | 1,907 | 1,936 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| | 2,219 | 3,577 | 4,265 |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| | | | |
+-----------------------------+---------------+---------------+---------------+
| Total equity and | 4,950 | 2,762 | 4,960 |
| liabilities | | | |
+-----------------------------+---------------+---------------+---------------+
Intercede Group plc
Consolidated Statement of Changes in Equity
+----------------------+----------+------------+------------+---------+------------+---------+
| | Share | Share | Other | Equity | Retained | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | Capital | Premium | reserves | reserve | earnings | Total |
+----------------------+----------+------------+------------+---------+------------+---------+
| | GBP'000 | GBP'000 | GBP'000 | GBP'000 | GBP'000 | GBP'000 |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| At 31 March 2009 | 4,305 | 2,875 | 1,508 | 109 | (8,102) | 695 |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Issue of shares, net | 108 | 1,843 | - | - | - | 1,951 |
| of costs | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Loan note conversion | - | - | - | (109) | 109 | - |
| - reversal of FRS25 | | | | | | |
| equity component | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Total comprehensive | - | - | - | - | 85 | 85 |
| income | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| At 30 September 2009 | 4,413 | 4,718 | 1,508 | - | (7,908) | 2,731 |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| At 31 March 2008 | 4,292 | 2,764 | 1,508 | 109 | (9,851) | (1,178) |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Issue of shares, net | 10 | 70 | - | - | - | 80 |
| of costs | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Total comprehensive | - | - | - | - | 283 | 283 |
| income | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| At 30 September 2008 | 4,302 | 2,834 | 1,508 | 109 | (9,568) | (815) |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| At 31 March 2008 | 4,292 | 2,764 | 1,508 | 109 | (9,851) | (1,178) |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Issue of shares, net | 13 | 111 | - | - | - | 124 |
| of costs | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| Total comprehensive | - | - | - | - | 1,749 | 1,749 |
| income | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| | | | | | | |
+----------------------+----------+------------+------------+---------+------------+---------+
| At 31 March 2009 | 4,305 | 2,875 | 1,508 | 109 | (8,102) | 695 |
+----------------------+----------+------------+------------+---------+------------+---------+
Intercede Group plc
Consolidated Cash Flow Statement
+---------------------------------+------------------+----------------+--------------+
| | 6 months ended | 6 months ended | Year ended |
+---------------------------------+------------------+----------------+--------------+
| | 30 September | 30 September | 31 March |
+---------------------------------+------------------+----------------+--------------+
| | 2009 | 2008 | 2008 |
+---------------------------------+------------------+----------------+--------------+
| | GBP'000 | GBP'000 | GBP'000 |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Cash flows from operating | | | |
| activities | | | |
+---------------------------------+------------------+----------------+--------------+
| Operating profit | 95 | 268 | 1,487 |
+---------------------------------+------------------+----------------+--------------+
| Depreciation | 15 | 12 | 25 |
+---------------------------------+------------------+----------------+--------------+
| Decrease/(increase) in trade | 214 | (441) | (483) |
| and other receivables | | | |
+---------------------------------+------------------+----------------+--------------+
| (Decrease)/increasein trade and | (111) | 701 | (1360) |
| other payables | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Cash generated from operations | 213 | 540 | 2,389 |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Taxation received | - | 61 | 61 |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Net cash from operating | 213 | 601 | 2,450 |
| activities | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Investing activities | | | |
+---------------------------------+------------------+----------------+--------------+
| Interest received | 18 | 22 | 68 |
+---------------------------------+------------------+----------------+--------------+
| Purchases of property, plant | (19) | (17) | (40) |
| and equipment | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Net cash from investing | (1) | 5 | 28 |
| activities | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Financing activities | | | |
+---------------------------------+------------------+----------------+--------------+
| (Cost)/proceeds on issue of | (10) | 80 | 80 |
| shares | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Net increase in cash and cash | 202 | 686 | 2,558 |
| equivalents | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Cash and cash equivalents at | 3,711 | 1,153 | 1,153 |
| the start of the period | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
| Cash and cash equivalents at | 3,913 | 1,839 | 3,711 |
| the end of the period | | | |
+---------------------------------+------------------+----------------+--------------+
| | | | |
+---------------------------------+------------------+----------------+--------------+
+------------------------------------------------------------------------------+-----------------+-----------------+-----------------+
| Intercede Group plc | | | |
+------------------------------------------------------------------------------+-----------------+-----------------+-----------------+
| Notes to the Accounts | | | |
+------------------------------------------------------------------------------+-----------------+-----------------+-----------------+
| | | | |
+------------------------------------------------------------------------------+-----------------+-----------------+-----------------+
| | | | |
+------------------------------------------------------------------------------+-----------------+-----------------+-----------------+
1. Preparation of the interim financial statements
These interim financial statements have been prepared under IFRS as adopted by
the European Union and on the basis of the accounting policies set out in the
Group's Annual Report for the year ended 31 March 2009.
The Group is not required to apply IAS 34 Interim Financial Reporting at this
time.
These interim financial statements have not been audited and do not constitute
statutory accounts as defined in Section 434 of the Companies Act 2006.
Statutory accounts for the year ended 31 March 2009 have been delivered to the
Registrar of Companies. The Auditors' Report on those accounts was unqualified
and did not contain any statement under Section 498 (2) or (3) of the Companies
Act 2006.
The Interim Report will be mailed to shareholders prior to the end of December
2009 and copies will be available on the website (www.intercede.com) and at the
registered office: Intercede Group plc, Lutterworth Hall, St Mary's Road,
Lutterworth, Leicestershire, LE17 4PS.
2. Segmental Reporting
All of the Group's revenue, operating profits and net assets originate from
operations in the United Kingdom. The Directors consider that the activities of
the Group constitute a single business segment.
+----------------------------+---------------+---------------+----------+
| The split of revenue by | | | |
| geographical destination | | | |
| of the end customer can be | | | |
| analysed as follows: | | | |
+----------------------------+---------------+---------------+----------+
| | 6 months | 6 months | Year |
| | ended | ended | ended |
+----------------------------+---------------+---------------+----------+
| | 30 September | 30 September | 31 March |
+----------------------------+---------------+---------------+----------+
| | 2009 | 2008 | 2009 |
+----------------------------+---------------+---------------+----------+
| | GBP'000 | GBP'000 | GBP'000 |
+----------------------------+---------------+---------------+----------+
| | | | |
+----------------------------+---------------+---------------+----------+
| United Kingdom | 795 | 882 | 2,488 |
+----------------------------+---------------+---------------+----------+
| Rest of Europe | 806 | 380 | 846 |
+----------------------------+---------------+---------------+----------+
| USA | 1,085 | 704 | 2,104 |
+----------------------------+---------------+---------------+----------+
| Rest of World | 125 | 15 | 263 |
+----------------------------+---------------+---------------+----------+
| | | | |
+----------------------------+---------------+---------------+----------+
| | 2,811 | 1,981 | 5,701 |
+----------------------------+---------------+---------------+----------+
3. Exceptional item
The exceptional item, which is included within administrative expenses,
represents the costs associated with defending a patent infringement lawsuit
which was filed by ActivIdentity in the United States District Court for the
Northern District of California on 1 October 2008.
No provision has been made as at 30 September 2009 in respect of the original
ActivIdentity lawsuit or contingent asset disclosed in respect of Intercede's
counterclaims.
4. Tax
There is no charge for corporation tax due to the availability of losses brought
forward from prior years.
5. Earnings per share
The calculation of earnings per ordinary share is based on the profit and the
weighted average number of ordinary shares in issue during each period i.e.
September 2009: 44,704,340; September 2008: 36,871,850 and March 2009:
37,011,460. The diluted earnings per share is based on a weighted average of
48,735,005 ordinary shares (September 2008 and March 2009: 48,785,009) which
reflects the potential exercise of all existing share options.
6. Dividend
The Directors do not recommend the payment of a dividend.
7. Analysis and reconciliation of net debt
+-----------------------------------+------------+-------------+-------------+
| | 6 months | 6 months | Year |
| | ended | ended | ended |
+-----------------------------------+------------+-------------+-------------+
| | 30 | 30 | 31 |
| | September | September | March |
+-----------------------------------+------------+-------------+-------------+
| | 2009 | 2008 | 2009 |
+-----------------------------------+------------+-------------+-------------+
| | GBP'000 | GBP'000 | GBP'000 |
+-----------------------------------+------------+-------------+-------------+
| | | | |
+-----------------------------------+------------+-------------+-------------+
| Cash and cash equivalents | 3,913 | 1,839 | 3,711 |
+-----------------------------------+------------+-------------+-------------+
| | | | |
+-----------------------------------+------------+-------------+-------------+
| Convertible loan notes | - | (1,907) | (1,936) |
+-----------------------------------+------------+-------------+-------------+
| | | | |
+-----------------------------------+------------+-------------+-------------+
| Net cash/(debt) | 3,913 | (68) | 1,775 |
+-----------------------------------+------------+-------------+-------------+
On 29 May 2009, notification was received from the remaining holders of the
convertible loan notes issued by the Company on 31 March 2000 and 6 December
2001 that they had elected to convert their loan notes together with associated
interest for the period to 31 May 2009 into ordinary shares of 1p each in the
Company. This resulted in the issue of 3,877,166 ordinary shares at a price of
15p per share and 6,897,083 ordinary shares at a price of 20p per share.
Following the conversion, the total issued share capital of the Company is
48,178,005 ordinary shares of 1p each.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR ILFSRFLLDIIA
Intercede (LSE:IGP)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Intercede (LSE:IGP)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
